Blaine Davis - 03 Jan 2025 Form 4 Insider Report for Cartesian Therapeutics, Inc. (RNAC)

Role
Chief Financial Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Blaine Davis
Issuer symbol
RNAC
Transactions as of
03 Jan 2025
Net transactions value
-$134,036
Form type
4
Filing time
07 Jan 2025, 20:04:49 UTC
Previous filing
06 Jan 2025
Next filing
06 Jan 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RNAC Common Stock Sale $66,235 -3,961 -3.9% $16.72 98,839 03 Jan 2025 Direct F1
transaction RNAC Common Stock Sale $67,800 -4,028 -4.1% $16.83 94,811 06 Jan 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.